Drug Type Fusion protein |
Synonyms TIM3 x CD40L (Shattuck Labs) |
Target |
Mechanism CD40 agonists(Tumor necrosis factor receptor superfamily member 5 agonists), CD47 inhibitors(Cluster of differentiation 47 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | - |